Literature DB >> 11984440

Epidemic Lymphogranuloma venereum during epidemics of crack cocaine use and HIV infection in the Bahamas.

J Eric Bauwens1, Herbert Orlander, M Perry Gomez, Mary Lampe, Stephen Morse, Walter E Stamm, Richard Cone, Rhoda Ashley, Paul Swenson, King K Holmes.   

Abstract

BACKGROUND: Since the early 1980s, the Bahamas has experienced sequential epidemics of freebase/crack cocaine use, genital ulcer-inguinal adenopathy disease (GUD), and heterosexual HIV infection. GOAL: To prospectively define the etiology of GUD in patients at the Princess Margaret Hospital during outbreaks of crack cocaine use, GUD, and HIV infection in the Bahamas. STUDY
DESIGN: In Nassau, 47 consecutive patients with GUD underwent serologic testing for syphilis and for infections with HIV, herpes simplex virus type 2 (HSV-2), and Chlamydia trachomatis. Genital ulcer specimens were tested by culture and/or polymerase chain reaction (PCR) assay for Haemophilus ducreyi; by PCR and/or antigen assay for HSV; and by PCR for C trachomatis. Lymph node aspirates were tested by PCR for C trachomatis and H ducreyi.
RESULTS: Twenty patients (43%) had HIV infection; eight had lymphogranuloma venereum (LGV), confirmed by PCR detection of C trachomatis sequences consistent with the L2 serovar; and nine others had possible LGV, on the basis of serum microimmunofluorescent C trachomatis antibody titers > or =256. Inguinal lymphadenopathy or bubo was present in 15 of 17 patients, who thus met the laboratory criteria for definite or possible LGV, and in 7 of 30 who did not meet such laboratory criteria (P < 0.001). Thirteen patients had confirmed genital herpes, seven had confirmed chancroid, and four had probable or possible primary syphilis.
CONCLUSIONS: The epidemics in the Bahamas of crack use, heterosexual HIV infection, and GUD apparently included epidemic transmission of LGV.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11984440     DOI: 10.1097/00007435-200205000-00001

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  19 in total

Review 1.  Lymphogranuloma venereum proctocolitis: a silent endemic disease in men who have sex with men in industrialised countries.

Authors:  R Martin-Iguacel; J M Llibre; H Nielsen; E Heras; L Matas; R Lugo; B Clotet; G Sirera
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-05-28       Impact factor: 3.267

2.  Emergence of lymphogranuloma venereum in Canada.

Authors:  Rhonda Y Kropp; Thomas Wong
Journal:  CMAJ       Date:  2005-05-31       Impact factor: 8.262

3.  Lymphogranuloma venereum.

Authors:  A Herring; J Richens
Journal:  Sex Transm Infect       Date:  2006-12       Impact factor: 3.519

4.  A chlamydial type III-secreted effector protein (Tarp) is predominantly recognized by antibodies from humans infected with Chlamydia trachomatis and induces protective immunity against upper genital tract pathologies in mice.

Authors:  Jie Wang; Lili Chen; Fan Chen; Xiaoyun Zhang; Yingqian Zhang; Joel Baseman; Sondra Perdue; I-Tien Yeh; Rochelle Shain; Martin Holland; Robin Bailey; David Mabey; Ping Yu; Guangming Zhong
Journal:  Vaccine       Date:  2009-03-10       Impact factor: 3.641

5.  Absence of lymphogranuloma venereum infection among high-risk men who have sex with men in Lima, Peru.

Authors:  Jesse L Clark; Benjamin Espinosa; Segundo R Leon; Eric R Hall; Hector J Salvatierra; Carlos F Cáceres; Jeffrey D Klausner; Thomas J Coates
Journal:  Int J STD AIDS       Date:  2008-06       Impact factor: 1.359

6.  Chlamydia trachomatis secretion of an immunodominant hypothetical protein (CT795) into host cell cytoplasm.

Authors:  Manli Qi; Lei Lei; Siqi Gong; Quanzhong Liu; Matthew P DeLisa; Guangming Zhong
Journal:  J Bacteriol       Date:  2011-03-25       Impact factor: 3.490

7.  Molecular diagnosis of lymphogranuloma venereum in patients with genital ulcer disease.

Authors:  Patrick D J Sturm; Prashini Moodley; Keshnie Govender; Louise Bohlken; Trusha Vanmali; A Willem Sturm
Journal:  J Clin Microbiol       Date:  2005-06       Impact factor: 5.948

8.  Increase in hepatitis C virus incidence in HIV-1-infected patients followed up since primary infection.

Authors:  J Ghosn; C Deveau; C Goujard; I Garrigue; N Saïchi; J Galimand; Z Nagy; C Rouzioux; L Meyer; M-L Chaix
Journal:  Sex Transm Infect       Date:  2006-08-21       Impact factor: 3.519

9.  Chlamydia-infected cells continue to undergo mitosis and resist induction of apoptosis.

Authors:  Whitney Greene; Yangming Xiao; Yanqing Huang; Grant McClarty; Guangming Zhong
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

10.  Caspase-1 contributes to Chlamydia trachomatis-induced upper urogenital tract inflammatory pathologies without affecting the course of infection.

Authors:  Wen Cheng; Pooja Shivshankar; Zhongyu Li; Lili Chen; I-Tien Yeh; Guangming Zhong
Journal:  Infect Immun       Date:  2007-11-19       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.